Cyclooxygenase-2: A Target for Chemoprevention and Treatment of Non–Small-Cell Lung Cancer (Q79278116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14609443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Cyclooxygenase-2: a target for chemoprevention and treatment of non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14609443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Cyclooxygenase-2: A Target for Chemoprevention and Treatment of Non–Small-Cell Lung Cancer (English)

1 reference

https://api.crossref.org/works/10.1016/S1525-7304(11)70292-3

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1525-7304(11)70292-3

31 March 2024

author name string

Angelia D. Gibson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609443

31 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14609443

31 March 2024

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14609443%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

https://api.elsevier.com/content/article/PII:S1525730411702923?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1525-7304(11)70292-3

https://api.elsevier.com/content/article/PII:S1525730411702923?httpAccept=text/plain

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1525-7304(11)70292-3

31 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14609443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14609443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14609443%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

273-276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14609443%20AND%20SRC:MED&resulttype=core&format=json

Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-7304%2811%2970292-3

7 January 2021

Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas

4

1 reference

https://api.crossref.org/works/10.1016/S1525-7304(11)70292-3

Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/S1525-7304(11)70292-3

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

31 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/S1525-7304(11)70292-3

Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs

31 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S1525-7304(11)70292-3

Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers

31 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/S1525-7304(11)70292-3